
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of Potential Serum Metabolic Biomarkers of Diabetic Kidney Disease: A Widely Targeted Metabolomics Study
Hang Zhang, Jingjing Zuo, Sisi Dong, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 39
Hang Zhang, Jingjing Zuo, Sisi Dong, et al.
Journal of Diabetes Research (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Metabolomics: A New Tool to Reveal the Nature of Diabetic Kidney Disease
Guoqing Huang, Mingcai Li, Yan Li, et al.
Laboratory Medicine (2022) Vol. 53, Iss. 6, pp. 545-551
Closed Access | Times Cited: 868
Guoqing Huang, Mingcai Li, Yan Li, et al.
Laboratory Medicine (2022) Vol. 53, Iss. 6, pp. 545-551
Closed Access | Times Cited: 868
Metabolomics as a tool for the early diagnosis and prognosis of diabetic kidney disease
Pedro Pereira, David F. Carrageta, Pedro F. Oliveira, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1518-1544
Closed Access | Times Cited: 88
Pedro Pereira, David F. Carrageta, Pedro F. Oliveira, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 4, pp. 1518-1544
Closed Access | Times Cited: 88
Metabolomics for Clinical Biomarker Discovery and Therapeutic Target Identification
Chunsheng Lin, Qianqian Tian, Sifan Guo, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2198-2198
Open Access | Times Cited: 16
Chunsheng Lin, Qianqian Tian, Sifan Guo, et al.
Molecules (2024) Vol. 29, Iss. 10, pp. 2198-2198
Open Access | Times Cited: 16
Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-κB– Dependent Inflammation
Xue Han, Jiajia Wei, Ruyi Zheng, et al.
Diabetes (2024) Vol. 73, Iss. 5, pp. 780-796
Open Access | Times Cited: 8
Xue Han, Jiajia Wei, Ruyi Zheng, et al.
Diabetes (2024) Vol. 73, Iss. 5, pp. 780-796
Open Access | Times Cited: 8
Serum kidney injury molecule 1 and β2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes
Marco Colombo, Helen C. Looker, Bassam Farran, et al.
Diabetologia (2018) Vol. 62, Iss. 1, pp. 156-168
Open Access | Times Cited: 64
Marco Colombo, Helen C. Looker, Bassam Farran, et al.
Diabetologia (2018) Vol. 62, Iss. 1, pp. 156-168
Open Access | Times Cited: 64
Non-invasive metabolic biomarkers for early diagnosis of diabetic nephropathy: Meta-analysis of profiling metabolomics studies
Amir Roointan, Yousof Gheisari, Kelly L. Hudkins, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 8, pp. 2253-2272
Closed Access | Times Cited: 33
Amir Roointan, Yousof Gheisari, Kelly L. Hudkins, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 8, pp. 2253-2272
Closed Access | Times Cited: 33
Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
Soumik Das, Gnanasambandan Ramanathan
Life Sciences (2023) Vol. 316, pp. 121414-121414
Closed Access | Times Cited: 14
Soumik Das, Gnanasambandan Ramanathan
Life Sciences (2023) Vol. 316, pp. 121414-121414
Closed Access | Times Cited: 14
Advancements, Challenges, and clinical implications of integration of metabolomics technologies in diabetic nephropathy
Vijay Sharma, Manoj Khokhar, Prasanta K. Panigrahi, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119842-119842
Closed Access | Times Cited: 5
Vijay Sharma, Manoj Khokhar, Prasanta K. Panigrahi, et al.
Clinica Chimica Acta (2024) Vol. 561, pp. 119842-119842
Closed Access | Times Cited: 5
Morinda officinalis polysaccharides improve meat quality by reducing oxidative damage in chickens suffering from tibial dyschondroplasia
Shucheng Huang, Qinqin Cao, Yabing Cao, et al.
Food Chemistry (2020) Vol. 344, pp. 128688-128688
Closed Access | Times Cited: 37
Shucheng Huang, Qinqin Cao, Yabing Cao, et al.
Food Chemistry (2020) Vol. 344, pp. 128688-128688
Closed Access | Times Cited: 37
Amino acid analysis as a method of discovering biomarkers for diagnosis of diabetes and its complications
Dan Cai, Biao Hou, Song Lin Xie
Amino Acids (2023) Vol. 55, Iss. 5, pp. 563-578
Closed Access | Times Cited: 11
Dan Cai, Biao Hou, Song Lin Xie
Amino Acids (2023) Vol. 55, Iss. 5, pp. 563-578
Closed Access | Times Cited: 11
Deliverables from Metabolomics in Kidney Disease: Adenine, New Insights, and Implication for Clinical Decision-Making
Nagarjunachary Ragi, Kumar Sharma
American Journal of Nephrology (2024) Vol. 55, Iss. 4, pp. 421-438
Open Access | Times Cited: 4
Nagarjunachary Ragi, Kumar Sharma
American Journal of Nephrology (2024) Vol. 55, Iss. 4, pp. 421-438
Open Access | Times Cited: 4
Application of Proteomics and Machine Learning Methods to Study the Pathogenesis of Diabetic Nephropathy and Screen Urinary Biomarkers
Xi Yan, Xinglai Zhang, Haiying Li, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 3612-3625
Closed Access | Times Cited: 4
Xi Yan, Xinglai Zhang, Haiying Li, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 8, pp. 3612-3625
Closed Access | Times Cited: 4
Hypoglycemic mechanism of foxtail millet prolamin hydrolysate in type 2 diabetic mice revealed by metabolomics and 16S rRNA sequencing
Yiqing Zhu, Tong Wu, Yongxia Fu, et al.
Food Bioscience (2025), pp. 106187-106187
Closed Access
Yiqing Zhu, Tong Wu, Yongxia Fu, et al.
Food Bioscience (2025), pp. 106187-106187
Closed Access
Lipidomics reveals potential biomarkers and pathophysiological insights in the progression of diabetic kidney disease
Xiaozhen Guo, Zixuan Zhang, Cuina Li, et al.
Metabolism Open (2025) Vol. 25, pp. 100354-100354
Open Access
Xiaozhen Guo, Zixuan Zhang, Cuina Li, et al.
Metabolism Open (2025) Vol. 25, pp. 100354-100354
Open Access
Metabolomics Based Exploration of the Mechanism of Action of Tripterygium Glycosides in Diabetic Kidney Disease
Long Li, Jianfeng Yu, Jing-song Jin, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 5
Closed Access
Long Li, Jianfeng Yu, Jing-song Jin, et al.
Biomedical Chromatography (2025) Vol. 39, Iss. 5
Closed Access
Predicting diabetic kidney disease with serum metabolomics and gut microbiota
Yuyun Hu, Ni Xue, Qinghuo Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yuyun Hu, Ni Xue, Qinghuo Chen, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review
Soumik Das, V. Devi Rajeswari, Ganesh Venkatraman, et al.
Translational research (2023)
Closed Access | Times Cited: 8
Soumik Das, V. Devi Rajeswari, Ganesh Venkatraman, et al.
Translational research (2023)
Closed Access | Times Cited: 8
Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications
Feixue Zhang, Shan Shan, Chen-Lu Fu, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2530-2530
Open Access | Times Cited: 2
Feixue Zhang, Shan Shan, Chen-Lu Fu, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2530-2530
Open Access | Times Cited: 2
Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
Xiaodie Mu, Min Yang, Peiyao Ling, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 247-256
Open Access | Times Cited: 10
Xiaodie Mu, Min Yang, Peiyao Ling, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 247-256
Open Access | Times Cited: 10
Application of Metabolomics and Traditional Chinese Medicine for Type 2 Diabetes Mellitus Treatment
Jing Li, Na Zhu, Yaqiong Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 4269-4282
Open Access | Times Cited: 5
Jing Li, Na Zhu, Yaqiong Wang, et al.
Diabetes Metabolic Syndrome and Obesity (2023) Vol. Volume 16, pp. 4269-4282
Open Access | Times Cited: 5
Serum metabolomics detected by LDI‐TOF‐MS can be used to distinguish between diabetic patients with and without diabetic kidney disease
Fengmei Qian, Li Zhao, Di Zhang, et al.
FEBS Open Bio (2023) Vol. 13, Iss. 10, pp. 1844-1858
Open Access | Times Cited: 4
Fengmei Qian, Li Zhao, Di Zhang, et al.
FEBS Open Bio (2023) Vol. 13, Iss. 10, pp. 1844-1858
Open Access | Times Cited: 4
Characteristics of dietary patterns, and serum metabolites during the low-gluten diet among Chinese young adults
Ning Wang, Qianhui Zhang, Li Zhang, et al.
Food Bioscience (2024) Vol. 61, pp. 104829-104829
Closed Access | Times Cited: 1
Ning Wang, Qianhui Zhang, Li Zhang, et al.
Food Bioscience (2024) Vol. 61, pp. 104829-104829
Closed Access | Times Cited: 1
Integration of texture analysis based on DCE-MRI Ktrans map and metabolomics of early bone marrow microvascular changes in alloxan-induced diabetic rabbits
Yan Wang, Liang Li, Yuchen Yan, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Yan Wang, Liang Li, Yuchen Yan, et al.
BMC Medical Imaging (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approaches
Muhammad Kashif, Sumaira Naz, Muhammad Zahoor, et al.
Open Chemistry (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Muhammad Kashif, Sumaira Naz, Muhammad Zahoor, et al.
Open Chemistry (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease
Claire Hill, Amy Jayne McKnight, Laura J. Smyth
Diabetic Medicine (2024)
Open Access | Times Cited: 1
Claire Hill, Amy Jayne McKnight, Laura J. Smyth
Diabetic Medicine (2024)
Open Access | Times Cited: 1